Lawrence Brian Lee

SEC source: 0001506228-26-000004 · wk-form4_1778013380.xml · nonDerivative · entry 1

Lawrence Brian Lee · CIK 0001506228 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,154

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs).

SEC source: 0001506228-26-000002 · wk-form4_1772227775.xml · nonDerivative · entry 1

Lawrence Brian Lee · CIK 0001506228 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,168

F1 · shares: These securities are Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on March 1, 2027 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.

SEC source: 0001388658-25-000112 · wk-form4_1746569209.xml · nonDerivative · entry 1

Lawrence Brian Lee · CIK 0001506228 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,479

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on May 1, 2026 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.

SEC source: 0001235802-24-000081 · primary_doc.xml · derivative · entry 5

LAWRENCE BRIAN · CIK 0001506228 · SVP & Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,834 shares

Expires 2033-01-02

F5 · derivative.exercise_date: This option, which provided for vesting as to 25% of the underlying shares on January 2, 2024, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Company common stock underlying the option, multiplied by (b) the excess, if any, of $2.18 over the per share exercise price of such option, which cash payment was $8,645.01. Pursuant to the Subscription Agreement, the reporting person agreed to use such proceeds to subscribe for Topco common units.

SEC source: 0001235802-24-000081 · primary_doc.xml · derivative · entry 4

LAWRENCE BRIAN · CIK 0001506228 · SVP & Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,625 shares

Expires 2032-05-10

F4 · derivative.exercise_date: This option, which provided for vesting as to 25% of the underlying shares on January 1, 2024, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Company common stock underlying the option, multiplied by (b) the excess, if any, of $2.18 over the per share exercise price of such option, which cash payment was $8,380.63. Pursuant to the Subscription Agreement, the reporting person agreed to use such proceeds to subscribe for Topco common units.

SEC source: 0001235802-24-000081 · primary_doc.xml · derivative · entry 3

LAWRENCE BRIAN · CIK 0001506228 · SVP & Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,550 shares

Expires 2032-01-01

F3 · derivative.exercise_date: This option, which provided for vesting as to 25% of the underlying shares on January 1, 2023 and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Company common stock underlying the option, multiplied by (b) the excess, if any, of $2.18 over the per share exercise price of such option, which cash payment was $4,490.75. Pursuant to the Subscription Agreement, the reporting person agreed to use such proceeds to subscribe for Topco common units.

SEC source: 0001235802-24-000081 · primary_doc.xml · nonDerivative · entry 2

LAWRENCE BRIAN · CIK 0001506228 · SVP & Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F2 · price: The restricted stock unit awards, which these shares were subject to, were canceled in the merger in exchange for a cash payment of $2.18 per underlying share. Pursuant to a Subscription Agreement (Subscription Agreement), dated as of September 20, 2024, between Topco and the reporting person, the reporting person agreed to use such proceeds to subscribe for Topco common units.

SEC source: 0001235802-24-000081 · primary_doc.xml · nonDerivative · entry 1

LAWRENCE BRIAN · CIK 0001506228 · SVP & Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · price: Disposed of pursuant to an Agreement and Plan of Merger, dated as of June 17, 2024, among Veronica Holdings, LLC (Topco), Veronica Intermediate Holdings, LLC, Veronica Merger Sub, Inc. and Vapotherm, Inc. (Company) and a Rollover Agreement, dated as of September 20, 2024, among Topco, the Company and the reporting person in exchange for an aggregate number of Topco common units at a price per unit of $2.18.

SEC source: 0001235802-24-000019 · primary_doc.xml · derivative · entry 7

LAWRENCE BRIAN · CIK 0001506228 · SVP & Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,834

Underlying: Common Stock · 6,834 shares

Expires 2033-01-02

F3 · price: The transactions reported herein reflect a stock option repricing effective February 27, 2024 pursuant to which the exercise price of the repriced options was amended to reduce the exercise price to $0.915 per share, the closing price of the Issuer's common stock on February 27, 2024. There is no change to the expiration dates or the vesting schedule of the repriced options.

F5 · derivative.exercise_date: This option vested as to 25% of the underlying shares on January 2, 2024, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, provided that the Reporting Person continues to serve as an employee or other service provider to the Issuer on each vesting date and otherwise subject to the Issuer's applicable equity incentive plan.

SEC source: 0001235802-24-000019 · primary_doc.xml · derivative · entry 6

LAWRENCE BRIAN · CIK 0001506228 · SVP & Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,834 shares

Expires 2033-01-02

F3 · price: The transactions reported herein reflect a stock option repricing effective February 27, 2024 pursuant to which the exercise price of the repriced options was amended to reduce the exercise price to $0.915 per share, the closing price of the Issuer's common stock on February 27, 2024. There is no change to the expiration dates or the vesting schedule of the repriced options.

F5 · derivative.exercise_date: This option vested as to 25% of the underlying shares on January 2, 2024, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, provided that the Reporting Person continues to serve as an employee or other service provider to the Issuer on each vesting date and otherwise subject to the Issuer's applicable equity incentive plan.

SEC source: 0001235802-24-000019 · primary_doc.xml · derivative · entry 5

LAWRENCE BRIAN · CIK 0001506228 · SVP & Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,625

Underlying: Common Stock · 6,625 shares

Expires 2032-05-10

F3 · price: The transactions reported herein reflect a stock option repricing effective February 27, 2024 pursuant to which the exercise price of the repriced options was amended to reduce the exercise price to $0.915 per share, the closing price of the Issuer's common stock on February 27, 2024. There is no change to the expiration dates or the vesting schedule of the repriced options.

F4 · derivative.exercise_date: This option vested as to 25% of the underlying shares on January 1, 2024, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, provided that the Reporting Person continues to serve as an employee or other service provider to the Issuer on each vesting date and otherwise subject to the Issuer's applicable equity incentive plan.

SEC source: 0001235802-24-000019 · primary_doc.xml · derivative · entry 4

LAWRENCE BRIAN · CIK 0001506228 · SVP & Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,625 shares

Expires 2032-05-10

F3 · price: The transactions reported herein reflect a stock option repricing effective February 27, 2024 pursuant to which the exercise price of the repriced options was amended to reduce the exercise price to $0.915 per share, the closing price of the Issuer's common stock on February 27, 2024. There is no change to the expiration dates or the vesting schedule of the repriced options.

F4 · derivative.exercise_date: This option vested as to 25% of the underlying shares on January 1, 2024, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, provided that the Reporting Person continues to serve as an employee or other service provider to the Issuer on each vesting date and otherwise subject to the Issuer's applicable equity incentive plan.

SEC source: 0001235802-24-000019 · primary_doc.xml · derivative · entry 3

LAWRENCE BRIAN · CIK 0001506228 · SVP & Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,550

Underlying: Common Stock · 3,550 shares

Expires 2032-01-01

F3 · price: The transactions reported herein reflect a stock option repricing effective February 27, 2024 pursuant to which the exercise price of the repriced options was amended to reduce the exercise price to $0.915 per share, the closing price of the Issuer's common stock on February 27, 2024. There is no change to the expiration dates or the vesting schedule of the repriced options.

F2 · derivative.exercise_date: This option vested as to 25% of the underlying shares on January 1, 2023 and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, provided that the Reporting Person continues to serve as an employee or other service provider to the Issuer on each vesting date and otherwise subject to the Issuer's applicable equity incentive plan.

SEC source: 0001235802-24-000019 · primary_doc.xml · derivative · entry 2

LAWRENCE BRIAN · CIK 0001506228 · SVP & Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,550 shares

Expires 2032-01-01

F3 · price: The transactions reported herein reflect a stock option repricing effective February 27, 2024 pursuant to which the exercise price of the repriced options was amended to reduce the exercise price to $0.915 per share, the closing price of the Issuer's common stock on February 27, 2024. There is no change to the expiration dates or the vesting schedule of the repriced options.

F2 · derivative.exercise_date: This option vested as to 25% of the underlying shares on January 1, 2023 and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, provided that the Reporting Person continues to serve as an employee or other service provider to the Issuer on each vesting date and otherwise subject to the Issuer's applicable equity incentive plan.

SEC source: 0001235802-23-000108 · primary_doc.xml · nonDerivative · entry 1

LAWRENCE BRIAN · CIK 0001506228 · SVP & Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,188

F1 · shares: This award was granted under the Vapotherm, Inc. Amended and Restated 2018 Equity Incentive Plan in the form of restricted stock units. The restricted stock units vest with respect to approximately one-fourth of the underlying shares on each of the one-year, two-year, three-year and four-year anniversaries of the grant date, subject to the Reporting Person's continued service as an employee or other service provider to the Issuer through the vesting dates.

F2 · balance_after: Includes 43,701 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Vapotherm, Inc. Amended and Restated 2018 Equity Incentive Plan.

F3 · balance_after: On August 18, 2023, a 1-for-8 reverse split of the common stock of Vapotherm, Inc. occurred resulting in a decrease in the number of shares held by the reporting person. In addition, proportionate adjustments have been made to the reporting person's outstanding equity awards, including the number of restricted stock units as reflected on this Form 4 and described in footnote (2) to this Form 4, to reflect the 1-for-8 reverse stock split.

SEC source: 0001235802-23-000007 · primary_doc.xml · derivative · entry 2

LAWRENCE BRIAN · CIK 0001506228 · SVP & Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,675

Underlying: Common Stock · 54,675 shares

Expires 2033-01-02

F3 · derivative.exercise_date: This option was granted under the 2018 Equity Plan and will vest as to 25% of the underlying shares on January 2, 2024, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, subject to the reporting person's continued service as an employee or other service provider to the Issuer through the vesting dates.

SEC source: 0001235802-23-000007 · primary_doc.xml · nonDerivative · entry 1

LAWRENCE BRIAN · CIK 0001506228 · SVP & Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 241,519

F1 · shares: Restricted stock unit award granted under the Vapotherm, Inc. Amended and Restated 2018 Equity Incentive Plan (the "2018 Equity Plan") in lieu of an annual increase in the reporting person's 2023 base salary. The restricted stock unit award will vest in full on December 31, 2023, subject to the reporting person's continued service as an employee or other service provider to the Issuer through the vesting date.

F1 · price: Restricted stock unit award granted under the Vapotherm, Inc. Amended and Restated 2018 Equity Incentive Plan (the "2018 Equity Plan") in lieu of an annual increase in the reporting person's 2023 base salary. The restricted stock unit award will vest in full on December 31, 2023, subject to the reporting person's continued service as an employee or other service provider to the Issuer through the vesting date.

F2 · balance_after: Includes 109,619 shares that will be issued over time upon vesting and settlement of restricted stock unit awards.

SEC source: 0001235802-22-000131 · primary_doc.xml · nonDerivative · entry 1

LAWRENCE BRIAN · CIK 0001506228 · SVP & Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 235,700

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.295 to $1.3792, inclusive. The reporting person undertakes to provide to Vapotherm, Inc., any security holder of Vapotherm, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

F2 · balance_after: Incudes 135,700 shares that will be issued over time upon vesting and settlement of restricted stock units granted under the Amended and Restated 2018 Equity Incentive Plan (as amended from time to time), subject to the reporting person's continued service as an employee or other service provider to the Issuer through the vesting dates.

SEC source: 0001235802-22-000115 · primary_doc.xml · nonDerivative · entry 1

LAWRENCE BRIAN · CIK 0001506228 · SVP & CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,700

F1 · shares: This award was granted under the Vapotherm, Inc. Amended and Restated 2018 Equity Incentive Plan (as amended from time to time, the "2018 Equity Plan") in the form of restricted stock units. The restricted stock units vest with respect to approximately one-third of the underlying shares on each of the one-year, two-year and three-year anniversaries of the grant date, subject to the Reporting Person's continued service as an employee or other service provider to the Issuer through the vesting dates.

F2 · balance_after: These shares will be issued over time upon vesting and settlement of restricted stock units granted under the 2018 Equity Plan, subject to the reporting person's continued service as an employee or other service provider to the Issuer through the vesting dates.

SEC source: 0001235802-22-000062 · primary_doc.xml · derivative · entry 2

LAWRENCE BRIAN · CIK 0001506228 · SVP & Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,000

Underlying: Common Stock · 53,000 shares

Expires 2032-05-10

F2 · derivative.exercise_date: This option was granted under the 2018 Equity Plan and will vest as to 25% of the underlying shares on January 1, 2024, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, subject to the reporting person's continued service as an employee or other service provider to the Issuer through the vesting dates.